This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 14 - 17, 2025
Marriott Marquis San Diego

Lin Yang
Associate Director of Discovery at Alloy Therapeutics
Speaker

Profile

Lin Yang is the Associate Director of Discovery at Alloy Therapeutics, where she leads multidisciplinary efforts to identify and advance novel therapeutic candidates. With deep expertise in antibody engineering and directed evolution, Lin oversees early-stage discovery programs from target validation through lead optimization. Her team leverages multiple display platforms to discover highly functional protein binders that align closely with each program’s target product profile. Before joining Alloy, Lin was a postdoctoral fellow in Dr. Sai Reddy’s group at ETH Zürich, where she led research integrating AI/ML with directed evolution to accelerate antibody discovery. Lin earned her PhD in Chemical and Biomolecular Engineering in Dr. Jamie Spangler’s lab at Johns Hopkins University, where her research focused on antibody engineering.

Agenda Sessions

  • From Difficult Targets to Drug Candidates: Alloy’s Integrated Platform for High- Affinity, Functional Antibody Discovery

    7:30am